`Pemphigus Antibody IgA

14-3-3 Protein Tau/Theta with Reflex to RT-QuIC Analysis, CSF

1p/19q Deletion by FISH

P1 Antigen Typing – Patient

p16 by Immunohistochemistry

p21 (Waf1/Cip 1) by Immunohistochemistry

P40 by Immunohistochemistry

P504S (AMACR) by Immunohistochemistry

P57 by Immunohistochemistry

Parainfluenza 1-4 by RT-PCR

p63 by Immunohistochemistry

Paraldehyde and Metabolite, Serum or Plasma

Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine

Paraneoplastic Antibodies (PCCA/ANNA) by IFA with Reflex to Titer and Immunoblot

Pain Management Drug Screen with Interpretation by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine

Paraneoplastic Antibodies (PCCA/ANNA) by IFA with Reflex to Titer and Immunoblot, CSF

Pain Management Panel, Screen with Reflex to Quantitation

Paraneoplastic Pemphigus Antibody Screen

Paired Helical Filament-Tau (PHF-Tau) by Immunohistochemistry

Parasite Examination, Macroscopic